💰Upcoming NIH Grant Evaluation Meetings and Opportunities
The National Institutes of Health is hosting a series of closed meetings to evaluate grant applications across various health and research topics. These meetings emphasize the importance of protecting confidential information while facilitating funding opportunities for researchers and organizations in the healthcare sector.
Learn More🧪Upcoming Closed Meetings for Grant Evaluations at NIH
The Department of Health and Human Services announces closed meetings for the Center for Scientific Review to evaluate grant applications in various scientific domains. The meetings are aimed at fostering advancements in health and bioengineering through collaboration, while ensuring that sensitive information remains confidential.
Learn More🏥NIH Notice
The Department of Health and Human Services announces closed meetings by the NIH Center for Scientific Review to evaluate grant applications related to infectious diseases and immunology. The meetings will be held virtually, focusing on confidential discussions of grant proposals that may include sensitive information.
Learn More🧪NIH Announces Closed Meetings for Grant Evaluations in April 2025
The Department of Health and Human Services has announced a series of closed meetings by the National Institutes of Health to review and evaluate grant applications. These meetings will cater to multiple health-related committees and provide a platform for discussing vital research and funding initiatives while ensuring confidentiality regarding the grant applications.
Learn More💰NIH Notice of Closed Meetings for Grant Evaluations
This notice from the Department of Health and Human Services details upcoming closed meetings regarding the review and evaluation of grant applications pertinent to various health-related committees. The meetings are conducted virtually, aimed at assessing funding opportunities for research in health sectors like neuroscience, immunology, and more.
Learn More💰NIH Closed Meetings on Grant Applications
The National Institutes of Health announces a series of closed meetings to evaluate grant applications across various scientific review committees. These sessions are crucial for organizations seeking financial support for research and development projects in healthcare, reflecting the agency’s focus on advancing scientific inquiry and innovation.
Learn More🛡️Notice on Antitrust Membership Changes for TReX II
The Department of Justice has issued a notice regarding changes in membership for the Training & Readiness Accelerator II (TReX II), associated with the National Cooperative Research and Production Act. The document outlines new members joining and others withdrawing from the venture, maintaining the group's ongoing activities and compliance with antitrust requirements.
Learn More📜Notice on R Consortium Membership Changes by DOJ Antitrust Division
The Department of Justice's Antitrust Division issued a notice regarding changes in membership within the R Consortium, Inc. This notice outlines the addition of new members and its implications for antitrust provisions under the National Cooperative Research and Production Act, emphasizing compliance requirements for participating businesses.
Learn More📡Changes in Utility Broadband Alliance Membership Notice
The Department of Justice issues a notice regarding membership changes in the Utility Broadband Alliance, Inc. under the National Cooperative Research and Production Act. The notice involves the addition of several companies to the alliance, while others have withdrawn, highlighting shifts in the strategic partnerships within the telecommunications sector.
Learn More💉Notice of NIH Grant Review Meetings - March 2025
The Department of Health and Human Services' National Institutes of Health has announced closed meetings to review grant applications related to infectious diseases and immunology. These meetings will evaluate proposals for research initiatives and are vital for stakeholders seeking funding in the healthcare sector, emphasizing the importance of protecting confidential information during the review process.
Learn More